1 |
Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options [J]. Nat Med, 2011, 17(11): 1410-1422.
|
2 |
Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use [J]. Circ Res, 2012, 110(4): 624-637.
|
3 |
Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells [J]. Arterioscler Thromb Vasc Biol, 2008, 28(9): 1584-1595.
|
4 |
Cui Y, Narasimhulu CA, Liu L, et al. Oxidized low-density lipoprotein alters endothelial progenitor cell populations [J]. Front Biosci (Landmark Ed), 2015, 20: 975-988.
|
5 |
Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk [J]. N Engl J Med, 2003, 348(7): 593-600.
|
6 |
Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood [J]. Blood, 2004, 104(9): 2752-2760.
|
7 |
Takizawa S, Nagata E, Nakayama T, et al. Recent progress in endothelial progenitor cell culture systems: potential for stroke therapy [J]. Neurol Med Chir (Tokyo), 2016, 56(6): 302-309.
|
8 |
Kaminski A, Ma N, Donndorf P, et al. Endothelial NOS is required for SDF-1alpha/CXCR4-mediated peripheral endothelial adhesion of c-kit+ bone marrow stem cells [J]. Lab Invest, 2008, 88(1): 58-69.
|
9 |
Everaert BR, Van Craenenbroeck EM, Hoymans VY, et al. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway [J]. Int J Cardiol, 2010, 144(3): 350-366.
|
10 |
Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand [J]. Cell, 2002, 109(5): 625-637.
|
11 |
Li WD, Li NP, Song DD, et al. Metformin inhibits endothelial progenitor cell migration by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the AMPK/mTOR/autophagy pathway [J]. Int J Mol Med, 2017, 39(5): 1262-1268.
|
12 |
Zhao G, Cheng XW, Piao L, et al. The soluble VEGF receptor sFlt-1 contributes to impaired neovascularization in aged mice [J]. Aging Dis, 2017, 8(3): 287-300.
|
13 |
Verloop RE, Koolwijk P, van Zonneveld AJ, et al. Proteases and receptors in the recruitment of endothelial progenitor cells in neovascularization [J]. Eur Cytokine Netw, 2009, 20(4): 207-219.
|
14 |
Liu ZJ, Tian R, Li Y, et al. SDF-1alpha-induced dual pairs of E-selectin/ligand mediate endothelial progenitor cell homing to critical ischemia [J]. Sci Rep, 2016, 6: 34416.
|
15 |
Sun M, Chen M, Liu Y, et al. Cathepsin-L contributes to cardiac repair and remodelling post-infarction [J]. Cardiovasc Res, 2011, 89(2): 374-383.
|
16 |
Mahpatra S, Firpo MT, Bacanamwo M. Inhibition of DNA methyltransferases and histone deacetylases induces bone marrow-derived multipotent adult progenitor cells to differentiate into endothelial cells [J]. Ethn Dis, 2010, 20(1 Suppl 1): S1-60-4.
|
17 |
Qu K, Wang Z, Lin XL, et al. MicroRNAs: key regulators of endothelial progenitor cell functions [J]. Clin Chim Acta, 2015, 448: 65-73.
|
18 |
Ishige-Wada M, Kwon SM, Eguchi M, et al. Jagged-1 signaling in the bone marrow microenvironment promotes endothelial progenitor cell expansion and commitment of CD133+ human cord blood cells for postnatal vasculogenesis [J]. PLoS One, 2016, 11(11): e0166660.
|
19 |
Chen CY, Su CM, Hsu CJ, et al. CCN1 promotes VEGF production in osteoblasts and induces endothelial progenitor cell angiogenesis by inhibiting miR-126 expression in rheumatoid arthritis [J]. J Bone Miner Res, 2017, 32(1): 34-45.
|
20 |
Mathiyalagan P, Liang Y, Kim D, et al. Angiogenic mechanisms of human CD34+ stem cell exosomes in the repair of ischemic hindlimb [J]. Circ Res, 2017, 120(9): 1466-1476.
|
21 |
Han X, Li P, Yang Z, et al. Zyxin regulates endothelial von Willebrand factor secretion by reorganizing actin filaments around exocytic granules[J]. Nat Commun, 2017, 8: 14639.
|
22 |
Malinverno M, Corada M, Ferrarini L, et al. Peg3/PW1 is a marker of a subset of vessel associated endothelial progenitors [J]. Stem Cells, 2017, 35(5): 1328-1340.
|
23 |
Zheng W, Huang R, Jiang B, et al. An early-stage atherosclerosis research model based on microfluidics [J]. Small, 2016, 12(15): 2022-2034.
|
24 |
马凤霞, 任倩, 韩忠朝. 植物血凝素样氧化型低密度脂蛋白受体介导氧化型低密度脂蛋白对内皮祖细胞存活和功能的影响 [J]. 中国医学科学院学报, 2007, 29(3): 336-341.
|
25 |
童海, 雷建军, 王仁, 等. 氨氯地平拮抗ox-LDL损伤大鼠骨髓源性内皮祖细胞血管样结构形成及机制 [J]. 2015, 23(3): 231-236.
|
26 |
Vega FM, Gautier V, Fernandez-Ponce CM, et al. The atheroma plaque secretome stimulates the mobilization of endothelial progenitor cells ex vivo [J]. J Mol Cell Cardiol, 2017, 105: 12-23.
|
27 |
Yu B, Chen Q, Le Bras A, et al. Vascular stem/progenitor cell migration and differentiation in atherosclerosis [J]. Antioxid Redox Signal, 2017. [Epub ahead of print]
|
28 |
刘楠, 褚现明, 安毅. 内皮祖细胞修复冠心病内皮损伤的研究进展 [J]. 医学综述, 2015, 21(14): 2546-2549.
|
29 |
Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents [J]. J Am Coll Cardiol, 2006, 48(12): 2584-2591.
|
30 |
Larsen K, Cheng C, Tempel D, et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model [J]. Eur Heart J, 2012, 33(1): 120-128.
|
31 |
Klomp M, Beijk MA, Varma C, et al. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents [J]. JACC Cardiovasc Interv, 2011, 4(8): 896-904.
|
32 |
Silber S, Damman P, Klomp M, et al. Clinical results after coronary stenting with the Genous Bio-engineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry [J]. EuroIntervention, 2011, 6(7): 819-825.
|
33 |
Woudstra P, Kalkman DN, den Heijer P, et al. 1-year results of the REMEDEE registry: clinical outcomes after deployment of the abluminal sirolimus-coated bioengineered (combo) stent in a multicenter, prospective all-comers registry [J]. JACC Cardiovasc Interv, 2016, 9(11): 1127-1134.
|
34 |
Kalkman DN, Woudstra P, Lu H, et al. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome[J]. Catheter Cardiovasc Interv, 2017, 90(2): E31-E37.
|
35 |
Zhu G, Wang J, Song M, et al. Overexpression of Jagged-1 ameliorates aged rat-derived endothelial progenitor cell functions and improves its transfusion efficiency for rat balloon-induced arterial injury [J]. Ann Vasc Surg, 2017, 41: 241-258.
|
36 |
李倩, 蔡丹, 刁鸿英, 等. 一种新型具有内皮祖细胞捕获能力的冠状动脉支架涂层材料体外血液相容性研究 [J/CD]. 中华临床医师杂志(电子版), 2013, 7(18): 117-119.
|
37 |
王娟, 周兵, 王欣欣, 等. Fe3O4纳米粒子与慢病毒载体共同感染内皮祖细胞的促血管新生和MRI示踪的应用 [J]. 高等学校化学学报, 2016, 37(6): 1148-1153.
|
38 |
Zhang F, Wang L, Li Y, et al. Optimizing mesoderm progenitor selection and three-dimensional microniche culture allows highly efficient endothelial differentiation and ischemic tissue repair from human pluripotent stem cells [J]. Stem Cell Res Ther, 2017, 8(1): 6.
|
39 |
Sharma B, Chang A, Red-Horse K. Coronary artery development: progenitor cells and differentiation pathways [J]. Annu Rev Physiol, 2017, 79: 1-19.
|